Indeed, the recent studies of Rush et al. [60] have reported that genetic activation of Nrf2 in Keap1FA/FA mice or pharmacologic Nrf2 activation via bardoxolone analog increase proteinuria in several mouse models of chronic kidney disease. This evidence concerns the gene NFE2L2 and chronic kidney disease.